Kamada Details Withholding Tax Procedures for $14.4M Cash Dividend
KMDA sits 46% above its 52-week low of $5.54.
Summary
Kamada announced updated withholding tax procedures for its $14.4 million cash dividend, including provisions for reduced tax rates for eligible Nasdaq shareholders and exemptions for Israeli corporate shareholders.
Key Events · Financing and Capital Events · KMDA
-
Tax Ruling Obtained for Cash Dividend
Kamada received a tax ruling from the Israel Tax Authority regarding the $0.25 per share cash dividend, totaling approximately $14.4 million, previously announced on March 11, 2026.
-
Reduced Withholding Tax for Eligible Shareholders
Nasdaq shareholders residing in countries with a tax treaty with Israel may be eligible for a reduced Israeli withholding tax rate on their dividend, subject to specific terms and documentation.
-
Exemption for Israeli Corporate Shareholders
Israeli corporate Nasdaq shareholders may qualify for an exemption from Israeli withholding tax on the dividend under the ruling's conditions.
-
Payment and Record Dates Confirmed
The dividend is expected to be paid on April 7, 2026, to shareholders of record as of March 23, 2026.
Analysis · KMDA · Life Sciences
Kamada Ltd. has secured a tax ruling from the Israel Tax Authority, providing crucial details on withholding tax procedures for its previously announced $0.25 per share cash dividend. This ruling allows eligible Nasdaq shareholders from countries with tax treaties with Israel to potentially benefit from a reduced withholding tax rate, and Israeli corporate shareholders may be exempt. This clarification is important for investors to understand the net proceeds from the significant $14.4 million dividend.
How filings like this one have moved
In the 30 days to Sep 13, 2026, 29.5% of the 1672 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was -0.22%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, KMDA was trading at $8.10 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $465.5M. The 52-week trading range was $5.54 to $9.35. This filing was assessed with positive market sentiment and an importance score of 7 out of 10.